Aspira Womens Health Q3 EPS $(0.48) Beats $(0.51) Estimate, Sales $2.22M Miss $2.91M Estimate
Portfolio Pulse from bharat@benzinga.com
Aspira Womens Health (NASDAQ:AWH) reported Q3 EPS of $(0.48), surpassing the $(0.51) estimate, but sales of $2.22M fell short of the $2.91M estimate. The EPS shows a 20% improvement, while sales increased by 7% compared to the same period last year.
November 13, 2023 | 9:18 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Aspira Womens Health reported better-than-expected Q3 EPS but missed revenue estimates, with a year-over-year improvement in both metrics.
While AWH beat EPS estimates, which could be seen as a positive sign, the miss on revenue estimates is significant and could dampen investor enthusiasm. The mixed results present both positive and negative signals to the market, leading to a neutral short-term impact score.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100